Sishuning Ciprofol Injection

1. Indications and Usage
Ciprofol injection is indicated for the induction and maintenance of general anesthesia in adult patients undergoing surgery or diagnostic procedures.
2. Dosage and Administration
Induction: Administered intravenously. The initial dose is typically titrated based on the patient’s age, weight, and clinical condition.
Maintenance: Can be used as a continuous infusion or repeated bolus doses.
Administration: Strictly for intravenous use. It must be administered by trained anesthesia professionals under continuous monitoring.
3. Mechanism of Action
Ciprofol is a short-acting anesthetic agent that acts primarily as a positive allosteric modulator of the GABA_A receptors in the central nervous system. It enhances the inhibitory neurotransmission of GABA, leading to sedative, hypnotic, and amnesic effects.
4. Safety and Warnings
Respiratory Depression: Dose-dependent respiratory depression and apnea can occur, particularly during induction. Airway patency and ventilation must be monitored closely.
Hypotension: A transient decrease in blood pressure is common immediately after induction.
Injection Site Pain: Pain at the injection site may occur, though it is generally less severe than with propofol.
Allergic Reactions: Hypersensitivity reactions, including anaphylaxis, have been reported.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: The most common adverse reactions include respiratory depression, hypotension, bradycardia, and injection site pain.
Clinical Research: Clinical trials have demonstrated that ciprofol provides effective induction and maintenance of anesthesia with favorable recovery profiles compared to traditional anesthetics.
6. Drug Interactions
CNS Depressants: Concomitant use with opioids, benzodiazepines, or other sedatives may potentiate the effects, leading to increased respiratory depression and hypotension.
CYP3A4 Inhibitors/Inducers: Drugs that affect the CYP3A4 metabolic pathway may alter the clearance and duration of action of ciprofol.
7. Pharmaceutical Information
Composition: The active ingredient is Ciprofol.
Appearance: White to off-white uniform emulsion.
Storage: Store at controlled room temperature and protect from light.